Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Extracellular proteins encompass a vast and heterogeneous group of proteins located outside the plasma membrane, including those secreted into bodily fluids and those constituting the extracellular matrix (ECM) (UniProt, 2024). They serve critical roles in maintaining tissue architecture, providing mechanical support, and facilitating intercellular communication through signaling molecules such as cytokines, growth factors, and hormones (NIH, 2023). While many specific members of this class—such as Vascular Endothelial Growth Factor (VEGF) or Tumor Necrosis Factor (TNF)—are pivotal therapeutic targets, the term 'Extracellular protein' itself is a general classification rather than a single target (Alberts et al., 'Molecular Biology of the Cell'). Dysregulation of these proteins is a hallmark of various pathologies, including cancer metastasis, where the ECM is remodeled, and chronic inflammatory diseases driven by secreted pro-inflammatory mediators (PubMed, 2022). In pharmacology, these proteins are frequently targeted by monoclonal antibodies designed to sequester ligands or block their interaction with cell-surface receptors. Because the term describes a subcellular location and functional state rather than a specific molecular entity, it does not possess a singular pharmacological profile or a unified set of interacting drugs.
As a broad category, there is no single mechanism of action; specific proteins within this class are targeted by neutralizing antibodies, decoy receptors, or enzyme inhibitors.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extracellular protein.